Alira Health Contributes to 2021 Bioregion Report on the Future of Catalan Life Sciences
Provides Key Trends in Market Access for Pharma and MedTech
January 27, 2022 – Alira Health, a global healthcare consulting and technology firm, announced that it is a key contributor to the just released 2021 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, conducted by Biocat, BioRegion of Catalonia together with CataloniaBio & HealthTech and ACCIÓ. Alira Health provided an in-depth analysis of market access trends, as well as tools to help understand the phases of market access in different countries, highlighting ways to ensure that the adoption of products (drugs, medical devices) is most effective.
Some key findings from the report –
- Health startups in the BioRegion raised €238 million in 2021, a new record.
- Venture capital remains the main source of investment, up 34% from 2020. 83% of the venture capital raised was from international investors.
- The medical technology subsector attracted the most investment while digital health companies saw investment nearly double from 2020.
This report was promoted by Biocat, CataloniaBio & HealthTech and ACCIÓ on January 25th at an event featuring the President of the Government of Catalonia and representatives from the sector.
“We are extremely pleased to contribute to this important annual report on the growth drivers and opportunities in the Catalan life sciences and health care ecosystem,” said Chus Castillo Gutierrez, Director of Global Market Access at Alira Health. “Alira Health has a very strong presence in Catalonia, with over 90 employees in our Barcelona office. We are deeply committed to supporting the growth and transformation of healthcare in Spain. This forward-looking report is an essential read for every healthcare organization who aspires to be a strong player in Catalonia as the region positions itself to be a leading European hub for emerging therapies and personalized medicine.”
About Alira Health
Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.
Our integrated and multidisciplinary team of over 500 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.